USD 0.92
(4.61%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 12.15 Million USD | -74.83% |
2022 | 48.31 Million USD | 10.93% |
2021 | 43.55 Million USD | 120.09% |
2020 | 19.79 Million USD | 33.28% |
2019 | 14.84 Million USD | -1.55% |
2018 | 15.08 Million USD | 46.38% |
2017 | 10.3 Million USD | -27.71% |
2016 | 14.25 Million USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 15 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 2.48 Million USD | -100.0% |
2024 Q2 | 2.38 Million USD | 0.0% |
2023 Q2 | 14.39 Million USD | 0.99% |
2023 Q1 | 14.24 Million USD | -70.51% |
2023 Q3 | 14.48 Million USD | 0.63% |
2023 FY | 12.15 Million USD | -74.83% |
2023 Q4 | 12.15 Million USD | -16.03% |
2022 Q1 | 47.66 Million USD | 9.44% |
2022 FY | 48.31 Million USD | 10.93% |
2022 Q4 | 48.31 Million USD | 0.26% |
2022 Q3 | 48.19 Million USD | 0.76% |
2022 Q2 | 47.82 Million USD | 0.33% |
2021 Q1 | 15.44 Million USD | -21.98% |
2021 Q3 | 42.65 Million USD | -2.27% |
2021 FY | 43.55 Million USD | 120.09% |
2021 Q4 | 43.55 Million USD | 2.12% |
2021 Q2 | 43.64 Million USD | 182.64% |
2020 Q4 | 19.79 Million USD | 19.17% |
2020 Q2 | 21.58 Million USD | 50.18% |
2020 Q3 | 16.6 Million USD | -23.06% |
2020 FY | 19.79 Million USD | 33.28% |
2020 Q1 | 14.37 Million USD | -3.21% |
2019 Q3 | 15.95 Million USD | -11.21% |
2019 FY | 14.84 Million USD | -1.55% |
2019 Q4 | 14.84 Million USD | -6.92% |
2019 Q2 | 17.96 Million USD | -16.79% |
2019 Q1 | 21.59 Million USD | 43.16% |
2018 Q4 | 15.08 Million USD | 98.0% |
2018 FY | 15.08 Million USD | 46.38% |
2018 Q1 | 11.16 Million USD | 8.36% |
2018 Q2 | 9.39 Million USD | -15.89% |
2018 Q3 | 7.61 Million USD | -18.88% |
2017 Q3 | 11.7 Million USD | -10.68% |
2017 Q4 | 10.3 Million USD | -11.96% |
2017 FY | 10.3 Million USD | -27.71% |
2017 Q1 | 14.35 Million USD | 0.7% |
2017 Q2 | 13.1 Million USD | -8.7% |
2016 FY | 14.25 Million USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | 14.25 Million USD | 0.6% |
2016 Q3 | 14.16 Million USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | -100.0% |
2012 FY | 15 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Bright Green Corporation | 201.78 Thousand USD | -5925.78% |
Alpha Teknova, Inc. | 13.25 Million USD | 8.241% |
ANI Pharmaceuticals, Inc. | 309.66 Million USD | 96.074% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | 86.65% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 97.518% |
Cosmos Health Inc. | 3.03 Million USD | -300.581% |
Journey Medical Corporation | 14.62 Million USD | 16.844% |
Embecta Corp. | 1.62 Billion USD | 99.252% |
Esperion Therapeutics, Inc. | 501.54 Million USD | 97.576% |
Dynavax Technologies Corporation | 252.41 Million USD | 95.183% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | 8.757% |
Pacira BioSciences, Inc. | 513.79 Million USD | 97.633% |
PainReform Ltd. | 30 Thousand USD | -40430.0% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -2155.698% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -2155.698% |
Safety Shot Inc | 304.9 Thousand USD | -3887.773% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -10280.862% |
Procaps Group, S.A. | 28.41 Million USD | 57.202% |
Theratechnologies Inc. | 51.26 Million USD | 76.28% |
Harrow Health, Inc. | 183.17 Million USD | 93.362% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -13875.862% |
Biofrontera Inc. | 804 Thousand USD | -1412.313% |
DURECT Corporation | 2.7 Million USD | -350.0% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 63.372% |
Cronos Group Inc. | 1.55 Million USD | -679.923% |
OptiNose, Inc. | 611 Thousand USD | -1890.016% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 97.56% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | 64.437% |
RedHill Biopharma Ltd. | 455 Thousand USD | -2572.308% |
Organogenesis Holdings Inc. | 60.74 Million USD | 79.984% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 4.89% |
Radius Health, Inc. | 339.66 Million USD | 96.42% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | -18.532% |
Phibro Animal Health Corporation | 458.28 Million USD | 97.347% |
Procaps Group S.A. | 28.41 Million USD | 57.202% |
Alvotech | 1.02 Billion USD | 98.817% |
TherapeuticsMD, Inc. | 6.53 Million USD | -86.145% |
Viatris Inc. | 16.18 Billion USD | 99.925% |
Rockwell Medical, Inc. | 8.29 Million USD | -46.618% |
Aytu BioPharma, Inc. | 10.87 Million USD | -11.786% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -3518.847% |
Tilray Brands, Inc. | 287.93 Million USD | 95.777% |
Lifecore Biomedical, Inc. | 120.51 Million USD | 89.91% |
Shineco, Inc. | 10.01 Million USD | -21.38% |
PetIQ, Inc. | 437.82 Million USD | 97.223% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Incannex Healthcare Limited | 210 Thousand USD | -5690.0% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | 95.293% |
Alimera Sciences, Inc. | 64.48 Million USD | 81.146% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 38.51 Million USD | 68.43% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -8900.733% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | -77.313% |
Clever Leaves Holdings Inc. | 720 Thousand USD | -1588.75% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -53978.456% |
Avadel Pharmaceuticals plc | 32.75 Million USD | 62.885% |
Hempacco Co., Inc. | 5.93 Million USD | -105.008% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 1.02 Billion USD | 98.817% |
Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 78.371% |
Lantheus Holdings, Inc. | 616.12 Million USD | 98.027% |
Currenc Group, Inc. | 2.5 Million USD | -385.007% |
Kamada Ltd. | 7.43 Million USD | -63.471% |
Indivior PLC | 235.66 Million USD | 94.841% |
Evoke Pharma, Inc. | 5 Million USD | -143.18% |
Flora Growth Corp. | 942 Thousand USD | -1190.764% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -53978.456% |
Evolus, Inc. | 120.35 Million USD | 89.898% |
HUTCHMED (China) Limited | 48.18 Million USD | 74.768% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 97.936% |
Akanda Corp. | 2.49 Million USD | -386.914% |